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Abstract
Background: To determine the incidence and prevalence of salivary gland tumours in the province of Valparaíso, 
Chile. 
Material and Methods: Retrospective review of salivary gland tumours diagnosed between the years 2000 and 
2011 from four local pathology services. Information on demographics and histopathology were retrieved from 
the medical records.
Results: The study sample consisted of 279 salivary gland tumours. Prevalence and incidence rates per 100.000 
persons were 15.4 and 2.51, respectively. Most of the neoplasms corresponded to benign tumours (70.3%). The 
most affected gland was the parotid gland. Pleomorphic adenoma was the most common benign tumour (53.8%) 
and mucoepidermoid carcinoma was the most common malignant tumour  (7.2%). 
Conclusions: Salivary gland tumours are uncommon neoplasms that usually arise in the parotid gland. Pleomor-
phic adenoma and mucoepidermoid carcinoma were the most common benign and malignant tumours reported 
in this series.  
Key words: Salivary gland tumours, benign tumours, malignant tumours, salivary glands neoplasms, cancer, 
neoplasia.
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Introduction
Salivary gland tumours represent an uncommon het-
erogeneous group of neoplasms with complex clinico-
pathological characteristics (1). The prevalence of these 
tumours varies between studies, but has been estimated 
to be 3-6% of all head and neck tumours (2).
Tumours of many different origins can arise in the sali-
vary glands. Some authors suggest that the histopathol-
ogy of these neoplasms is more complex and diverse 
than any other site in the body (3). The World Health 
Organisation (WHO) proposed the first histological 
classification of salivary gland tumours in 1972 (4). 
Due to advances in the understanding of the aetiology 
and behaviour of these tumours as well as their wide 
morphological diversity, the WHO published the third 
and last edition of this classification in 2005 (5).
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The glands most commonly affected are the parotid and 
submandibular glands respectively, usually by benign 
tumours (6). When the minor salivary glands are af-
fected, it is usually by malignant tumours and almost 
every tumour arising from the sublingual gland is ma-
lignant (3).  
Many studies have been performed in order to describe 
the epidemiology of benign and malignant salivary 
gland tumours (1-3,6,7). The incidence, prevalence, age, 
gender, anatomical distribution and survival rates var-
ies between different parts of the world (3,6) and is not 
necessarily representative of the population of Chile. To 
our knowledge there is only one study published in the 
literature performed in a Chilean population but this 
study included a considerable smaller sample size and 
was conducted in another area of the country. 
It is important to note that this is the first study that 
characterises patients diagnosed with salivary gland tu-
mours in the province of Valparaiso-Chile, presenting 
information on the incidence and prevalence in one of 
the most important geographical areas of Chile.
Material and Methods
Data from salivary gland tumours diagnosed between 
the years 2000 and 2011 was collected from four local 
Oral and General Pathology services (Hospital Dr. Gus-
tavo Fricke, Hospital Carlos van Buren, Hospital Naval 
NEF and the Histopathology Laboratory of the Dentist-
ry Faculty of Universidad Andrés Bello). Informed con-
sent was obtained from each patient. In case the patient 
had died, a close relative was contacted in order to ob-
tain informed consent. Reference populations for each 
of the centres was recorded in order to calculate  preva-
lence and incidence rates. All four centres together have 
an estimated population of 1.3645.000.
Cases were included if the diagnosis was confirmed his-
topathologically and where age, gender and site of the 
tumour were recorded in the medical records. All cases 
were classified under the histological criteria suggest-
ed by the WHO in 2005 (5). Tumours diagnosed using 
the 1991 WHO classification criteria for salivary gland 
tumours were revised by an expert pathologist and as-
signed a new diagnosis based on the 2005 WHO clas-
sification criteria. 
Cases were excluded if the histopathological diagno-
sis, gender, age and/or site of the tumour were missing. 
Squamous cell carcinomas and non-epithelial tumours 
arising in minor salivary glands were excluded because 
of the uncertainty of the origin of those tumours. 
The chi-square test was used for the comparison of 
qualitative variables. A P-value of 0.05 or less was con-
sidered significant. 
Ethical approval was sought and obtained from the ethi-
cal committee of the Dentistry Faculty of Universidad 
Andres Bello.
Results 
Between the years 2000 and 2011, 279 salivary gland 
tumours were diagnosed in the province of Valparaiso. 
The prevalence was 15.24 per 100.000 and the incidence 
was 2.51 per 100.000.   
Forty one point nine percent (n= 117) of the tumours 
occurred in men and 58.1% (n= 162) occurred in wom-
en. One hundred and ninety six tumours (70.3%) were 
benign and 83 (29.7%) were malignant. Of the benign 
tumours, 80 (40.8%) occurred in men and 116 (59.2%) 
occurred in women. Of the malignant tumours, 37 
(44.6%) occurred in men and 46 (55.4%) in women. The 
mean age for benign and malignant tumours was 53.3 
± 19.09 and 60.9 ± 26.6 years respectively. Two hun-
dred fifty nine tumours (92.8%) were primary epithelial 
neoplasms, 19 (6.8%) were primary non-epithelial neo-
plasms and only one tumour (0.4%) was a metastasis. 
- Primary epithelial tumours:
The distribution of the primary epithelial tumours 
(n=259) is shown in table 1. The parotid gland was the 
most commonly affected site (n=151) followed by the 
submandibular gland (n=49) and the palatal salivary 
glands (n=29). There were 188 (72.6%) benign epithelial 
tumours and 71 (27.4%) malignant epithelial tumours. 
The majority of the tumours diagnosed in the major 
salivary glands were benign neoplasms with a benign-
malignant ratio of 3.9:1. The benign-malignant ratio in 
the minor salivary glands was 1:1. 
The pleomorphic adenoma (Fig. 1) was the most com-
mon tumour with a total of 150 cases, representing 
53.8% of all tumours (epithelial and non-epithelial) and 
57.9% of the epithelial tumours. The Warthin tumor 
was the second most common tumour with 23 cases 
(8.2%). Both lesions showed a predilection for the pa-
rotid gland, which was statistically significant when the 
different locations of these two tumours (p<0.001) was 
compared. There were no cases of epithelial tumours 
affecting the sublingual glands. The mucoepidermoid 
carcinoma (Fig. 2) and the adenoid cystic carcinoma 
(Fig. 3) were the third and fourth most prevalent lesions 
respectively. The mucoepidermoid carcinoma affected 
the major and minor salivary glands evenly, while the 
majority of the adenoid cystic carcinomas were found 
to affect the minor salivary glands. 
The distribution of epithelial tumours by gender is 
shown in table 2. The male to female ratio was 1:1.35. 
The male to female ratio for benign and malignant tu-
mours was 1:1.41 and 1:1.22 respectively. The majority 
of the pleomorphic adenomas were found in women (91 
of the 150 tumours), which was statistically significant 
(p=0.009). Sixteen of the 23 cases of Warthin tumour 
were found in men, but this difference was not found to 
be statistically significant (p= 0.061).
There was a wide age distribution for the salivary gland 
tumours in this study, with a range of 4 to 87 years (av-
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Table 1. Primary epithelial tumours.
P<0,001.
Major Salivary Glands Minor Salivary Glands 
Parotid Submaxillary Palatal Buccal mucosa Upper lip Lower lip 
Benign tumors nº % nº % nº % nº % nº % nº % 
Pleomorphic adenoma 95 63,3 31 20,7 12 8,0 6 4,0 6 4,0 - - 
Warthin tumor 20 87,0 1 4,3 1 4,3 1 4,3 - - - - 
Basal cell adenoma 5 71,4 - - - - 1 14,3 1 14,3 - - 
Oncocytoma 3 100,0 - - - - - - - - - - 
Cystadenoma 2 66.6 1 33.3 - - - - - - - - 
Sebaceous adenoma - - - - - - 1 100,0 - - - - 
Myoepithelioma 1 100,0 - - - - - - - - - - 
Total 126 67,0 33 17,6 13 6,9 9 4,8 7 3,7 - - 
Malignant tumors nº % nº % nº % nº % nº % nº % 
Mucoepidermoid carcinoma 6 30,0 4 20,0 5 25,0 1 5,0 - - - - 
Adenoid cystic carcinoma 2 15,4 3 23,1 5 38,5 - 2 15,4 - - 
Adenocarcinoma, not otherwise specified 4 30,8 4 30,8 2 15,4 2 15,4 - - 1 7,7 
Polymorphous low-grade adenocarcinoma - - - 3 50,0 1 16,7 - - 2 33,3 
Acinic cell carcinoma 3 75,0 - - 1 25,0 - - - - - - 
Carcinoma ex pleomorphic adenoma 3 75,0 1 25,0 - - - - - - - - 
Non-specified carcinoma 2 66,7 1 33,3 - - - - - - - - 
Squamous cell carcinoma 2 66,7 1 33,3 - - - - - - - - 
Salivary duct carcinoma 1 50,0 1 50,0 - - - - - - - - 
Carcinosarcoma 1 100,0 - - - - - - - - - - 
Epithelial-myoepithelial carcinoma - - 1 100,0 - - - - - - - - 
 Large cell carcinoma 1 1,4 - - - - - - - - - - 
Total 25 35,2 16 22,5 16 22,5 4 5,6 2 2,8 3 4,2 
Fig. 1. Pleomorphic adenoma: A.Well defined, round to ovoid tumour located in the left side of the hard palate. B. Proliferation of epithe-
lial and myoepithelial cells, some with plasmacytoid appearance, forming duct-like structures containig eosinophilic secretory material 
with a mesenchimal myxoid component (HE, 10x).
A B
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erage 53.3 ± 19 years). The average age for men and 
women was 55 ± 18.4 and 52.1 ± 19.3 years respectively. 
The average age at which benign tumours were diag-
nosed was of 50.7 ± 19.2 years while malignant tumours 
were diagnosed at an average age of 60.2 ± 16.9 years. 
The differences between age of appearance of malig-
nant and benign tumours were statistically significant 
(p=0.03).  
- Primary non-epithelial tumors:
Nineteen tumours (6.8%) of the total of 279 tumours 
were non-epithelial. Of the non-epithelial tumours, 11 
cases (58%) were lymphomas, and four cases were lipo-
mas (21%) (Table 3). 
The distribution of the non-epithelial tumours according 
to gender and location is shown in table 3. The majority 
of the tumours (n=14) were located in the parotid gland, 
which was statistically significant (p=0.001). The non-
epithelial tumours affected women more commonly, 
particularly the lymphomas, but these differences were 
not statistically significant (p=0.366). 
- Metastasis:
There was only one case recorded as a metastasis, which 
accounted for 0.4% of the total number of tumours. This 
was found in the parotid gland of a man of 65 years and 
was diagnosed as metastasis of a renal clear cell adeno-
carcinoma.
 
Discussion
This is the first study that reports on the incidence and 
prevalence of salivary gland tumours in the province of 
Valparaíso- Chile. A total of 279 salivary gland tumours 
were analysed in this review and together with an esti-
mated population assigned to each hospital (1.3645.000 
people) it was possible to calculate the prevalence and 
incidence, which were 15.4 and 2.51 cases per 100,000 
respectively. It is difficult to make comparisons with 
other studies because these measures are not often re-
ported in this type of series. 
Seventy point three percent and 29.7% of the tumours 
were benign and malignant respectively. A Brazilian 
study of 493 salivary gland tumours (8,9) reported  a 
distribution of 74.8% benign and 25.1% malignant tu-
mours. Another study performed in a Brazilian popula-
tion (7) reported a distribution of 67.5% and 32.5% be-
nign and malignant neoplasms respectively. A Chinese 
series of 6982 salivary gland neoplasms (2), reported 
C
A B
Fig. 2. Mucoepidermoid carcinoma: A. Ill-defined, ulcerated, erythematous mass located on the left hard palate. B: Sheets of squamous and 
mucous producing cells forming cystic spaces. (HE 10x) C: Cystic space linned by numerous, large, mucous producing cells. (HE; 40x).
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68% benign and 32% malignant cases.  An Iranian study 
of 130 cases (9) found 68.2% benign and 31.8% malig-
nant tumours. Although these reports are from different 
geographical areas, they are very similar between each 
other and to the present review, suggesting that benign 
salivary gland tumours are more common than malig-
nant tumours worldwide, with an estimated prevalence 
between 67 and 75% of all salivary gland neoplasms. 
According to the WHO and other reports (5,8) and in 
agreement with the present results, female patients 
are overall more affected than men, although there are 
some studies that report higher prevalence’s in men 
(3,9,10,11). These differences may be explained due to 
geographical variations of the populations.
It is reported that mesenchimal tumours account for 
1.9% to 5% (12) of all salivary gland tumours. Taka-
hama et al. (12) reported in their series of 600 cases that 
95% of the tumours were of epithelial origin, while the 
remaining 5% were of non-epithelial origin. The major-
ity of the cases in the present review were of epithelial 
origin (92.8%) with only 19 cases (6.8%) of non-epi-
thelial origin, which is slightly different than the other 
reports.  
Tian et al. (2) and Li et al. (10) reported in their series 
that the majority of primary epithelial salivary gland 
neoplasms were located in major salivary glands, es-
pecially the parotid gland. In the present study 77.22% 
of the primary epithelial tumours compromised major 
salivary gland with a marked predilection for the pa-
rotid gland, making it the most affected gland. The 
minor salivary glands together were the second more 
common location, representing 22.78% of the cases. 
The submandibular gland was the third most frequent 
location. This distribution corresponds well to previ-
ous reports (2,3,10,13). Some authors (1) have reported 
the submandibular gland to be the second most affected 
gland followed by the minor salivary glands. These dif-
ference may be due the fact that these authors do not 
reported the prevalence of tumours in minor salivary 
gland as a whole group, reporting the prevalence per 
location (palatal, labial, buccal, etc.). There were no pri-
mary epithelial tumours affecting the sublingual gland 
Fig. 3. Adenoid cystic carcinoma: A. Ill-defined mass on the right side of the hard palate with an erythematous surface. B: Adenoid cystic car-
cinoma, cribiform pattern: proliferation of ductal and miopepithelial cells with hyperchromatic nuclei, arranged in nests forming microcystic 
spaces filled with basophilic mucoid material, separated by hyalinized fibrous conective tissue. (HE, 10x) 3. C: Perineural invasion, a common 
feature of adenoid cysic carcinoma (HE, 40x).
A B
C
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in the present series confirming the low frequency of 
these tumours in this location.  
The majority of the epithelial tumours were benign 
(72.6%), similar to that which has been reported by 
other authors (3,8,9). Forty nine point two percent of the 
tumours in the minor salivary glands were located in 
the palate. Sixteen of them were malignant and 13 were 
benign. While this suggests that malignant neoplasms 
are more common than benign neoplasms in the minor 
salivary glands of the palate, the difference was not sta-
Gender 
Male  Female 
Benign tumours n  % n  % Nº  % 
Pleomorphic adenoma 59  39,3 91  60,7 150  57,9 
Warthin tumor 16  69,9 7  31,4 23  8,9 
Basal cell adenoma -  - 7  100 7  2,7 
Oncocytoma  -  - 3  100 3  1,1 
Papillary cystadenoma 1  33,3 2  66,6 3  1,2 
Sebaceous adenoma 1  100 -  - 1  0,4 
Myoepithelioma 1  100 -  - 1  0,4 
Total 78  41,5 110  58,5 188  72,6 
Malignant tumours n  % n  % Nº  % 
Mucoepidermoid carcinoma 10  50 10  50 20  7,7 
Adenoid cystic carcinoma 4  30,8 9  69,2 13  5 
Adenocarcinoma, not otherwise specified 8  61,5 5  38,5 13  5 
Polymorphous low-grade adenocarcinoma 2  33,3 4  66,7 6  2,3 
Acinic cell carcinoma -  - 4  100 4  1,5 
Carcinoma ex pleomorphic adenoma 1  25 3  75 4  1,5 
Non-specified carcinoma 2  66,7 1  33,3 3  1,2 
Squamous cell carcinoma 2  66,7 1  33,3 3  1,2 
Salivary duct carcinoma 2  100 -  - 2  0,8 
Carcinosarcoma 1  100 -  - 1  0,4 
Epithelial-myoepithelial carcinoma 1  100 -  - 1  0,4 
 Large cell carcinoma -  - 1  100 1  0,4 
Total 32  45,1 39  54,9 71  27,4 
Table 2. Primary epithelial tumours by gender.
p=0,009.
Parotid gland Submaxillargland
Sublingual
gland
Male Female Male Female Male Female Total
n n n n n n Nº 
Lymphoma 2 7 2 - - - 11
Lipoma 2 1 - 1 - - 4
Lymphangioma - 1 - - - - 1
Schwannoma - 1 - - - - 1
Haemangioma - - - 1 - - 1
Angiofibroma - - - - - 1 1
Total 4 10 2 2 - 1 19
Table 3. Non-epithelial tumours.
p= 0,001.
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tistically significant. These findings are consistent with 
those reported in the literature (1,7,9,13-19).
When analysing the epithelial tumours by histological 
type, the most prevalent neoplasm was the pleomorphic 
adenoma (57.9%). The most frequent location of this 
lesion was the parotid, submandibular and minor pala-
tal salivary glands respectively, similar to that which 
has been reported in other studies (1,6-9,13,15,19-22). 
Warthin tumor was the second most common lesion, 
corresponding to 8.2% of all epithelial tumours. Simi-
lar studies reported this tumour to be the third or fourth 
most common type, being outnumbered by the mucoep-
idermoid carcinoma and/or the adenoid cystic carcino-
ma. All reports agreed that the most common location 
is the parotid gland (1,6,7,9,13,15,16,19-22).
The mucoepidermoid carcinoma represented the third 
most common tumour and was the most frequent malig-
nant neoplasm, followed by the adenoid cystic carcino-
ma and adenocarcinoma not otherwise specified. These 
results are similar to previous series (2,3,6,7,10,13,15). 
Some of these studies reported that the mucoepider-
moid carcinoma was the most common malignant tu-
mour and others suggested that the adenoid cystic car-
cinoma was the most common. These differences may 
be explained due to regional variations regarding to age, 
gender and race.
Most of the pleomorphic adenomas were found in fe-
males, which was statistically significant (p= 0.009). 
Similar results have also been found by other authors 
(7,8). Warthin tumour was found more frequently in 
males, which has also been reported by other series 
(2,3,7-9) In relation to mucoepidermoid and  adenoid 
cystic cell carcinoma, the present and other published 
series have not been able to established a gender predi-
lection for either lesion. 
The average age of presentation for the primary epi-
thelial tumours was 53.3 years, which varied consider-
ably between the benign and malignant tumours. The 
benign neoplasms occurred at an average age of 50.7, 
whereas the malignant  neoplasms occurred at an aver-
age age of 60.6. This corresponds to previous studies 
which have estimated that malignant neoplasms occur 
approximately a decade later when compared to benign 
tumours (1,7,9,13-19).
In relation to the non-epithelial neoplasms, the parotid 
gland was the most  commonly affected gland (73.7%) 
followed by the submandibular (21%) and the sublin-
gual (5.3%) glands respectively. This is similar to the 
findings reported by Cho et al. (11). In their study, the 
parotid gland was the most commonly affected gland 
with 83.3% of the cases, followed by the submandibular 
gland with 17.7% of the cases. The authors reported no 
tumours in the sublingual gland. In the present series, 
lymphoma corresponded to the most prevalent histo-
logic type, with 58% of the cases followed by lipomas 
with 21% of the cases. According to the gender distribu-
tion of these neoplasms there was a M:F ratio of 1:1.38 
which is very similar to the one reported by Cho et al. 
(11), which was 1:1.25. The average age for this group of 
patients was 53.2 years. 
Most lymphomas were located in the parotid gland, 
which was statistically significant (p=0,035). There was 
a tendency to affect women more than men, but this was 
not statistically significant. The average age of presen-
tation for this neoplasm was 65.36 years. Considering 
the low prevalence of lymphomas in the head and neck 
region and given the location, age and gender of these 
patients, it is possible that could have be affected by 
Sjögren’s syndrome. It has been reported that lympho-
mas arise in 4-10% of patients with Sjögren’s Syndrome 
(22). Unfortunately that information was not available 
from the medical records.
  
Conclusion
Salivary gland tumours are uncommon neoplasms that 
usually arise in the parotid gland showing some pre-
dilection for females. Benign tumours are by far more 
common than malignant tumours. Pleomorphic ad-
enoma and mucoepidermoid carcinoma were the most 
common benign and malignant tumours reported in this 
series respectively. Almost half of the tumours arising 
from minor salivary glands were malignant, so special 
care must be taken when these glands are affected. 
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